Who is mahima datla?
Who is mahima datla?
Mahima Datla has been with Biological E. Limited since 2001 and is currently its Managing Director. During this period, she has been involved in project management, building quality systems and driving operations at the company. She engages with the Government of India and GAVI on public policy.
Who is owner of Biological E?
Founded and led by Dr. DVK Raju, Biological E. Limited commenced its operations in 1953 as a biological products company manufacturing liver extracts and anti-coagulants.
Is Biological E Limited MNC?
Biological E Limited (also known as BioE) is an Indian biotechnology and biopharmaceutical company based in Hyderabad, Telangana….Biological E. Limited.
| Type | Private |
|---|---|
| Founder | Datla Venkata Krishnam Raju |
| Headquarters | Jubilee Hills, Hyderabad, Telangana, India |
| Key people | Mahima Datla (Managing Director) |
| Number of employees | 2500 |
Is biological EA public company?
Biological E Ltd. is not listed on NSE (View BSE)
What is the name of Biological E vaccine?
Biological E collaborated with the Texas Children’s Hospital and the Baylor College to develop CORBEVAX vaccine. Dynavax, Inc from US supported CORBEVAX development by providing the adjuvant and THSTI Delhi conducted key immunogenicity testing as part of a comprehensive clinical trial development plan.
Is Bharat Biotech listed company?
It’s a public unlisted company and is classified as’company limited by shares’.
Who is manufacturing Covaxin?
COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).
What is the name of the Indian COVID-19 vaccination registrations online platform?
Where can I register for COVID-19 vaccination? You can open the Co-WIN portal using the link www.cowin.gov.in and click on the “Register/Sign In” tab to register for COVID-19 vaccination, and follow the steps thereafter.
Who found Covaxin?
COVAXIN® – India’s First Indigenous COVID-19 Vaccine. COVAXIN®, India’s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).
Who is CEO of Bharat Biotech?
Dr. Krishna Ella is the Chairman & Managing Director of Bharat Biotech International Limited, which he incorporated in 1996.
Is COVAXIN approved in India?
India’s 1st COVID-19 Vaccine – COVAXIN™, Developed by Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials .
How is COVAXIN different from Covishield?
Compared to the Covaxin vaccination for Corona, the COVID vaccine Covishield has more side effects. The side effects such as headache, vomiting, nausea, and fever are also more intense. In very rare cases of 1 in 100,000 people, Covishield can also lead to blood clots.
